K2 Oncology
PrivateLast Round
Series B
Aug 4, 2022
Total Funding Raised
$1.5M
Company Overview
K2 Oncology is a biotechnology company that specializes in organoid technology, providing anti-tumor drug R&D services and precision medicine solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
K2 Oncology Comparables
Compare K2 Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AimingMed | 89% | |
| D1 Medical Technology | 88% | |
| bioGenous Biotechnology | 87% | |
K2 Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 4, 2022 | ||||
| Series A | Aug 1, 2018 | ||||
| Angel | Sep 1, 2016 |
K2 Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Delian Capital | Series A |
| Tongsheng Capital | Series A |
| Zhongguancun Development Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 4, 2022
Completed a Series B funding round.
- Aug 1, 2018
Led by Delian Capital with participation from Tongsheng Capital and Zhongguancun Development Group.
K2 Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about K2 Oncology's valuation, stock price, and market status.